Europe’s scientific edge
in early schizophrenia diagnosis
VOLABIOS is an innovative European research project aiming to revolutionize the early diagnosis of schizophrenia. By leveraging advanced technologies, such as Multi-Omics approaches, mobile spectrometry (volatolomics), and artificial intelligence, VOLABIOS is paving the way for groundbreaking solutions to detect and understand this complex mental health condition.
Schizophrenia affects approximately 80 million people worldwide, severely impacting the lives of patients and their families. VOLABIOS is dedicated to introducing innovative, costeffective tools that improve diagnostic accuracy by up to 30%, reduce diagnostic timelines, and enable timely interventions that can transform patient outcomes.
We revolutionize diagnostics with cutting-edge technology:
- Innovative Diagnostic Methods
- Artificial Intelligence
- European Collaboration
Our project is designed to enhance global healthcare systems, support future research, and create an open-access knowledge base for the international community. Together, we are building a brighter future for diagnosing and treating complex mental disorders.
Early Detection of Schizophrenia Through Science and Innovation
Schizophrenia remains one of the most complex and challenging mental health conditions to diagnose early and accurately. Traditional methods often result in late detection and misdiagnosis, delaying access to proper treatment and support. VOLABIOS addresses this gap by introducing a revolutionary, non-invasive approach to early schizophrenia (SZ) detection.
VOLABIOS project brings together advanced portable spectrometry, multi-omics analysis, and VOC biomarker validation to create a comprehensive diagnostic framework. By focusing on early-stage identification — even before symptoms fully emerge — VOLABIOS enables faster diagnosis, reduces clinical uncertainty, and supports better patient outcomes.
Using real-time Ion Mass Spectrometry (IMS) and innovative digital tools, VOLABIOS delivers accessible, low-cost diagnostic solutions that are validated through extensive clinical studies involving over 3,600 participants across Europe. At its core, the project combines cutting-edge science with co-design and citizen engagement to ensure its tools are practical, ethical, and ready for real-world healthcare systems.
VOLABIOS is not just about technology — it’s about transforming mental healthcare, starting with how we detect and understand schizophrenia.
Explore our glossary page for clear explanations of all key terms used in VOLABIOS.
- Cell.
- Consecte.
- Immunology
- Equipment.
- Consecte.
- Equipment.
- Immunology
- Medicine.
- Scientific.
- Consecte.
- research.
- Scientific.
- Medicine.
- Immunology
Key facts
Project Partners
Project’s research phases
- Analysis of 9 million medical records, including 120,000 linked to schizophrenia.
- Clinical monitoring of more than 3,500 patients across six European medical centers for up to 36 months.
- Blind study with 1,000 participants to validate biomarkers and assess their efficacy.
VOLABIOS aims to improve schizophrenia diagnosis by reducing errors and enabling early interventions. Through innovative tools and open-access knowledge, it advances mental health research globally.
Focusing Your Mind, with The
Best Expert.
“I greatly appreciate the communication on the very hard process, what we needed to do in terms of providing good samples, what to expect. Novalab laboratory provided tests what we needed in terms of laboratory certification that we can use with our customers.”
“I greatly appreciate the communication on the very hard process, what we needed to do in terms of providing good samples, what to expect. Novalab laboratory provided tests what we needed in terms of laboratory certification that we can use with our customers.”
“I greatly appreciate the communication on the very hard process, what we needed to do in terms of providing good samples, what to expect. Novalab laboratory provided tests what we needed in terms of laboratory certification that we can use with our customers.”
What our clients say About us
Quasi architebeat vitae dicta sunt explicabo nemo enim ipsam volup tatem quia voluptassit aspernatur aut odit fugit sed quia consequuntur magni dolores eos.
On the other hand we denounce with righteous indignation and dislike men who are so beguiled .
